TransMedics Group, Inc. (TMDX)

73.94 +0.72 (+0.98%) At close: 04:00PM EST

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900
https://www.transmedics.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 212

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Waleed H. Hassanein M.D.	Founder, President, CEO & Director	1.46M	2.21M	1968
Mr. Stephen Gordon	CFO, Treasurer & Secretary	744.62k	2.55M	1968
Dr. Tamer I. Khayal M.D.	Chief Commercial Officer	748.78k	3.15M	1969
Ms. Miriam C. Provost Ph.D.	Vice President of Global Regulatory Affairs	535.93k	390.25k	1961
Mr. Nick Corcoran	Senior Vice President of Supply Chain & Operations	N/A	N/A	1982
Mr. Mark Anderson	Senior Director of Technology Development	N/A	N/A	N/A
Mr. Anil Ranganath	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	N/A
Ms. Susan Goodman	Vice President of Human Resources	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Corporate Governance

TransMedics Group, Inc.’s ISS Governance QualityScore as of December 1, 2023 is 3. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.